Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled study.

Objectives:To investigate the effect of low-dose, long-term recombinant human growth hormone (rhGH) therapy on immune reconstitution in human immunodeficiency virus (HIV)-infected patients with focus on thymic index, density and output.Design:Randomized, placebo-controlled, double-blind, single-cent